Gene · 6161
RPL32: ribosomal protein L32
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. RPL32: ribosomal protein L32. Genes, record 6161. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/6161
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P62910 | Large ribosomal subunit protein eL32 | 135 | 177 | Ensembl, GeneID, HGNC |
Source UniProt
Patents106
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 11429 | P62910 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 5971 | P62910 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 11429 | P62910 | Espacenet |
| KR 1020250017231 A | 2025-02-04 | 5971 | P62910 | Espacenet |
| US 11694765 B2 | 2023-07-04 | 270 | P62910 | Espacenet |
| US 11694765 B2 | 2023-07-04 | 272 | P62910 | Espacenet |
| US 11694765 B2 | 2023-07-04 | 274 | P62910 | Espacenet |
| US 11564998 B2 | 2023-01-31 | 6969 | P62910 | Espacenet |
| US 11564998 B2 | 2023-01-31 | 6970 | P62910 | Espacenet |
| US 11564998 B2 | 2023-01-31 | 7602 | P62910 | Espacenet |
1 to 10 of 106
See all 106 patentsDrugs9
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
| Drug | ChEMBL ID | Mechanism | Action | Source |
|---|---|---|---|---|
| ATALUREN | CHEMBL256997 | 80S Ribosome modulator | MODULATOR | ChEMBL |
| CITATUZUMAB BOGATOX | CHEMBL1743000 | 80S Ribosome inhibitor | INHIBITOR | ChEMBL |
| CYCLOHEXIMIDE | CHEMBL123292 | 80S Ribosome inhibitor | INHIBITOR | ChEMBL |
| DORLIMOMAB ARITOX | CHEMBL2109124 | 80S Ribosome inhibitor | INHIBITOR | ChEMBL |
| ELX-02 | CHEMBL4297744 | 80S Ribosome modulator | MODULATOR | ChEMBL |
| MT-3724 | CHEMBL4297789 | 80S Ribosome inhibitor | INHIBITOR | ChEMBL |
| TAPLITUMOMAB PAPTOX | CHEMBL2107890 | 80S Ribosome inhibitor | INHIBITOR | ChEMBL |
| TELIMOMAB ARITOX | CHEMBL2108790 | 80S Ribosome inhibitor | INHIBITOR | ChEMBL |
| ZOLIMOMAB ARITOX | CHEMBL2108785 | 80S Ribosome inhibitor | INHIBITOR | ChEMBL |
Trials38
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
| Trial | Drug | Phase | Results first posted | Source |
|---|---|---|---|---|
| NCT07523581 | ELX-02 | PHASE2 | ClinicalTrials.gov | |
| NCT05448755 | ELX-02 | PHASE2 | 2026-02-24 | ClinicalTrials.gov |
| NCT04336826 | ATALUREN | PHASE2 | 2024-04-01 | ClinicalTrials.gov |
| NCT04135495 | ELX-02 | PHASE2 | ClinicalTrials.gov | |
| NCT04126473 | ELX-02 | PHASE2 | ClinicalTrials.gov | |
| NCT04117880 | ATALUREN | PHASE2 | ClinicalTrials.gov | |
| NCT04069260 | ELX-02 | PHASE2 | ClinicalTrials.gov | |
| NCT04014530 | ATALUREN | PHASE1/PHASE2 | ClinicalTrials.gov | |
| NCT03796637 | ATALUREN | PHASE2 | 2022-04-05 | ClinicalTrials.gov |
| NCT03645395 | MT-3724 | PHASE2 | 2022-08-16 | ClinicalTrials.gov |
1 to 10 of 38
See all 38 trialsNIH grants1,342
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | RPL32 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 14 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 7 | 2025 |
| P30CA047904 | Cancer Center Support Grant | 7 | 2025 |
| P30CA006927 | Comprehensive Cancer Center Program at Fox Chase | 6 | 2025 |
| P30CA013330 | Cancer Center Support Grant | 6 | 2025 |
| P40OD018537 | Bloomington Drosophila Stock Center at Indiana University | 6 | 2025 |
| P30CA125123 | Baylor College of Medicine Cancer Center - Cancer Center Support Grant | 5 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 4 | 2025 |
| P30CA091842 | Cancer Center Support Grant | 4 | 2025 |
| P51OD011092 | Support for National Primate Research Center | 4 | 2025 |
1 to 10 of 1,342Source NIH's project files
See all 1,342 nih grantsPapers1,739
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The complete Chloroplast Genome of Dianthus Helenae, an Endemic Species with Medicinal Potential from the Nuratau Mountains, Uzbekistan. | F1000Res | 2026 | 42732172 | PubTator, text mining | PubMed |
| Rubus chingii chloroplast genome sequences: a comparative analysis with other Rubus L.chloroplast genomes. | BMC Genomics | 2026 | 42410352 | PubTator, text mining | PubMed |
| Phylogenomics, divergence time estimation, and biogeography of Iris species from Kazakhstan using plastome sequence analysis. | Front Plant Sci | 2026 | 42389122 | PubTator, text mining | PubMed |
| Phylogenomic discordance among plastid genes in endangered Maltese Limonium. | Sci Rep | 2026 | 42288520 | PubTator, text mining | PubMed |
| RPL32: From housekeeping gene to potential biomarker and therapeutic target in cancer and multiple system diseases. | Cancer Treat Res Commun | 2026 | 42225004 | PubTator, text mining | PubMed |
| Strip1 Is a Novel Negative Regulator of Cardiomyocyte Hypertrophy. | Cells | 2026 | 41892331 | PubTator, text mining | PubMed |
| Dataset on intergenic spacer sequences of the chloroplast genome and potential DNA barcodes of Adinandra glischroloma Hand.-Mazz. from Vietnam. | Data Brief | 2026 | 41800390 | PubTator, text mining | PubMed |
| Dissecting the role of imiquimod and isostearic acid in Aldara-induced psoriasis mouse model. | JID Innov | 2026 | 41769206 | PubTator, text mining | PubMed |
| Manganese modulates hepatocellular carcinoma cytotoxicity and doxorubicin sensitivity in a dose dependent manner. | Front Oncol | 2026 | 41768239 | PubTator, text mining | PubMed |
| Assembly of the Delphinium densiflorum Chloroplast Genome and Comparative Genomics Within Delphinium. | Genes (Basel) | 2026 | 41751624 | PubTator, text mining | PubMed |
1 to 10 of 1,739
See all 1,739 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/6161
GET https://conductscience.org/api/genes/v1/6161/patents?page=2